Research and experimental development on natural sciences and engineering
LYTIX BIOPHARMA ASA
Revenue 2024
NOK 11.1m
Operating profit
NOK −95.9m
Equity
NOK 107.9m
Incorporated
2003
Employees
6
Share capital
NOK 7.7m
Organisation
Employees
6
Established
2003-07-01
Industry code
72.100
Legal form
ASA
Group structure
Eier · 10.1%
JAKOB HATTELAND HOLDING AS
Company
LYTIX BIOPHARMA ASA
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Utvikling av produkter for salg eller lisensiering til større legemiddelfirmaer inne kreft eller infeksjonsterapi.
Business address
Sandakerveien 138, 0484 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.